Page last updated: 2024-10-30

mechlorethamine and Persistent Fetal Circulation Syndrome

mechlorethamine has been researched along with Persistent Fetal Circulation Syndrome in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cech, P1
Testa, U1
Dubart, A1
Schneider, P1
Bachmann, F1
Guerrasio, A1
Beuzard, Y1
Schmidt, PM1
Clément, F1
Rosa, J1

Other Studies

1 other study available for mechlorethamine and Persistent Fetal Circulation Syndrome

ArticleYear
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
    Acta haematologica, 1982, Volume: 67, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin

1982